Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Prostate Health Market Grown from 2024 to 2025?
The progression of the prostate health market in recent years has been vigorous, escalating from $34.07 billion in 2024 to $37.34 billion in 2025 with a compound annual growth rate (CAGR) of 9.6%. The factors contributing to the substantial growth in the past years can be attributed to the aging population, advancement in hormone therapy, increased screenings for PSA, rising awareness campaigns, and growing incidence rates.
What Growth Rate Is Anticipated for the Prostate Health Market in the Coming Years?
In the coming years, the prostate health market is predicted to experience robust growth, with projections showing an expansion to $53.25 billion in 2029, at a compound annual growth rate (CAGR) of 9.3%. This growth during the projected period can be linked to the rising acceptance of precision medicine, increased implementation of AI-facilitated diagnoses, advancement of target-specific radiotherapies, heightened demand for minimally invasive treatments, and enhanced methods of genetic risk evaluation. Some significant trends for the forecast period include the harnessing of artificial intelligence for risk calculation, developments in liquid biopsy, cutting-edge radiotheranostics, innovations in immunotherapy, and real-time biomarker tracking.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21265&type=smp
Who Are the Leading Companies in the Prostate Health Market?
Major companies operating in the prostate health market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Bayer AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Genentech Inc., Teleflex Inc., Elekta AB, Myriad Genetics Inc., Freenome, Theragenics Corporation, CureVac BV, ArsenalBio, Roivant Sciences, Artera Inc., Veru Inc., HistoSonics Inc., Immunic Inc., Ezra, Francis Medical, CorTechs Labs, Lucida Medical, Serimmune Inc., Alessa Therapeutics.
What Are the Key Drivers of the Prostate Health Market?
The increase in prostate cancer occurrences is anticipated to drive the expansion of the prostate health market. Prostate cancer develops when cells in the prostate gland proliferate uncontrollably, typically appearing as adenocarcinomas, the most prevalent form of this disease in men. The surge in prostate cancer is chiefly attributed to an aging population, expanded screening habits, and lifestyle aspects such as obesity and lack of physical activity. Maintaining prostate health is crucial in preventing, detecting early, and managing prostate cancer. For example, in January 2023, the American Cancer Society (ACS), a non-profit organization located in the US, predicted approximately 288,300 new cases of prostate cancer to be diagnosed in the States, with an estimated 34,700 fatalities due to the disease. Consequently, the escalating incidence of prostate cancer is forecasted to stimulate the growth of the prostate health market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21265&type=smp
What Are the Key Market Segments in the Prostate Health Industry?
The prostate health market covered in this report is segmented –
1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis
2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments
3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels
Subsegments:
1) By Prostate Cancer: Localized Prostate Cancer, Metastatic Prostate Cancer
2) By Benign Prostate Hyperplasia: Mild BPH, Moderate BPH, Severe BPH
3) By Prostatitis: Acute Bacterial Prostatitis, Chronic Bacterial Prostatitis, Chronic Prostatitis (Non-Bacterial)
What Are the Latest Trends in the Prostate Health Market?
In order to maintain a competitive advantage, prominent businesses in the prostate health sector are focusing on technological advancements like AI-powered risk assessments. This technology harnesses machine learning algorithms to analyze data and forecast potential risks, thereby aiding in sound decision making and enhancing results. Taking an example from September 2024, Nanostics Inc., a Canadian clinical-stage biotechnology firm, teamed up with Protean BioDiagnostics, a US-based biotech company, to introduce CDX Prostate. The tool, which targets men at high risk of aggressive prostate cancer, combines biological data, clinical data, and AI-enabled learning models to create a risk rating. It employs sophisticated machine learning algorithms to scrutinize a mix of biological and clinical data, thereby offering a more precise risk score for aggressive prostate cancer than conventional methods. This testing aids medical practitioners and patients in deciding about moving forward with a biopsy following a heightened prostate-specific antigen (PSA) test result or an abnormal digital rectal exam (DRE).
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/prostate-health-global-market-report
What Are the Key Regional Markets in the Prostate Health Industry?
North America was the largest region in the prostate health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21265
This Report Delivers Insight On:
1. How big is the prostate health market, and how is it changing globally?
2. Who are the major companies in the prostate health market, and how are they performing?
3. What are the key opportunities and risks in the prostate health market right now?
4. Which products or customer segments are growing the most in the prostate health market?
5. What factors are helping or slowing down the growth of the prostate health market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model